News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
321 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18770)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (335)
2 (389)
3 (283)
4 (319)
5 (131)
6 (6)
7 (4)
8 (279)
9 (329)
10 (321)
11 (307)
12 (125)
13 (3)
14 (8)
15 (254)
16 (287)
17 (204)
18 (246)
19 (94)
20 (14)
21 (3)
22 (244)
23 (272)
24 (225)
25 (255)
26 (87)
27 (4)
28 (5)
29 (233)
30 (284)
31 (251)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Virpax to Initiate Investigational New Drug (IND) Enabling Studies for Epoladerm(TM)
Virpax Pharmaceuticals Inc. (NASDAQ:VRPX), today announced that it has signed an agreement with Charles River Laboratories to initiate preclinical studies of Epoladerm
March 10, 2021
·
4 min read
Business
Konica Minolta Precision Medicine collaborates with AWS to create the next generation of precision diagnostics
Konica Minolta Precision Medicine, Inc. ( KMPM ) announced today a five-year collaboration with Amazon Web Services, Inc. (AWS). As the Preferred Cloud Provider for KMPM, AWS will support the build-out of the company’s LATTICE™ initiative globally.
March 10, 2021
·
3 min read
Business
Firma Clinical Commences Scientific Advisory Board
Firma Clinical, a niche service provider to clinical research organizations, recently commenced a Scientific Advisory Board for its clinical services, including biometrics/data.
March 10, 2021
·
9 min read
Genetown
Onduo Achieves URAC Telemedicine Accreditation
Onduo, a virtual and digital chronic care management service, was recently awarded full URAC Accreditation in Telemedicine for its consumer to provider virtual telemedicine platform.
March 10, 2021
·
3 min read
Business
AbCellera-Discovered Bamlanivimab Together with Etesevimab Reduced Hospitalizations and Prevented Death in Phase 3 Trial for Early COVID-19
AbCellera (Nasdaq: ABCL) today announced that bamlanivimab (LY-CoV555) 700 mg, a human antibody discovered by AbCellera and developed with Eli Lilly and Company (Lilly), and etesevimab 1400 mg (LY-CoV16) together reduced COVID-19-related hospitalization
March 10, 2021
·
7 min read
Pharm Country
Annovis Bio Receives Japanese Patent for the Treatment of Acute Brain or Nerve Injury
“This new patent further strengthens our intellectual property focused on the treatment of neurodegenerative diseases,” commented Maria Maccecchini, Ph.D., CEO of Annovis.
March 10, 2021
·
3 min read
Business
Tryp Therapeutics Appoints Luke Hayes as Chief Financial Officer
Mr. Hayes has been active in the life science industry for more than 20 years with experience in technology transfer, venture capital, and finance.
March 10, 2021
·
4 min read
Drug Development
Transgene Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination With Avelumab Versus Avelumab Monotherapy in Patients With HPV16-positive Anogenital Cancers
- Enrollment of the first patient is expected in Q2 2021 - Trial will focus on patients without liver metastases, based on encouraging data in Phase Ib/II study - Trial targets indications where clinical outcomes can be improved versus standard therapeutic options and immune checkpoint inhibitors (“ICIs”) - Continued clinical collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to conduct the expanded Phase II study
March 10, 2021
·
16 min read
BioMidwest
Research Solutions to Participate in the Virtual 33rd Annual ROTH Conference
Research Solutions, Inc., a pioneer in providing cloud-based workflow solutions for R&D driven organizations, announced that it will participate in the Virtual 33rd Annual ROTH Conference, taking place March 15-17, 2021.
March 10, 2021
·
1 min read
Pharm Country
Researchers Identify RNA Editing Events that Impact Gene Expression and Phenotype
Combining computational mining of big data with experimental testing in the lab, researchers at Children’s Hospital of Philadelphia have identified RNA editing events that influence gene expression and, in turn, the phenotypic manifestation of that expression.
March 10, 2021
·
3 min read
Previous
28 of 33
Next